US Patent Issued to THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE, BRITISH COLUMBIA CANCER AGENCY BRANCH, THE UNIVERSITY OF BRITISH COLUMBIA on Jan. 20 for "Compositions, methods and kits for characterizing and screening for small cell ovarian carcinoma" (Canadian, American Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,529,108, issued on Jan. 20, was assigned to THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (Phoenix), BRITISH COLUMBIA CANCER AGENCY BRANCH (Vancouver, Canada) and THE UNIVERSITY OF BRITISH COLUMBIA (Vancouver, Canada).

"Compositions, methods and kits for characterizing and screening for small cell ovarian carcinoma" was invented by Pilar Ramos (Phoenix), William Hendricks (Phoenix), David Craig (Phoenix), Jeffrey M. Trent (Phoenix), Anthony N. Karnezis (Vancouver, Canada), David Huntsman (Vancouver, Canada), Hongwei Holly Yin (Phoenix) and Yemin Wang (Vancouver, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates composit...